COMMUNIQUÉS West-GlobeNewswire

BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
05/10/2026
- October 6 YouTube premiere featuring Sway Calloway, Howard “H” White and leading medical and cultural voices anchors community education nationwide PALO ALTO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma [...]
iCell Gene Therapeutics Announces Upcoming Conference Presentations
05/10/2026
STONY BROOK, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- iCell Gene Therapeutics ("iCell Gene"), a clinical-stage biopharmaceutical company developing autologous and in vivo CAR T cell therapies for autoimmune diseases and [...]
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
05/10/2026
ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable target Cancer Research UK to fully fund, sponsor, design, and execute CTA-enabling studies and Phase 1/2 [...]
Major shareholder announcement - BlackRock, Inc.
05/10/2026
ANNOUNCEMENT NO. 318 5 October 2026 Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec that, on 29 September 2026, BlackRock, Inc. increased its [...]
FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms
05/10/2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Click Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (marketing authorization) for Motivista, a prescription [...]
Cerene® Cryotherapy Brings Free Mother-Daughter Period Education Brunch to Indianapolis Area
05/10/2026
CARMEL, Ind., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems’ Cerene® Cryotherapy is bringing its Cycles & Seasons Mother-Daughter Brunch to the Indianapolis area on Saturday, October 10, offering local [...]
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
05/10/2026
Company Announcement COPENHAGEN, Denmark and NORTH CHICAGO, Ill.; October 5, 2026 EPCORE DLBCL-2 is the first Phase 3 study of a bispecific antibody combination therapy to demonstrate statistically significant and [...]
Baylor Genetics Selected as the Lead Sequencing Partner for Florida’s Sunshine Genetics Pilot Program Launch
05/10/2026
The company will provide comprehensive Whole Genome Sequencing for the initial launch of the first statewide genomic newborn screening program HOUSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading [...]
Frederick Breathe Free Celebrates Dr. Jamie Oberman’s Recognition as a 2026 Castle Connolly Top Doctor
05/10/2026
Dr. Oberman’s recognition highlights his commitment to thoughtful, patient-centered ENT care at Frederick Breathe Free. Frederick, MD, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Frederick Breathe Free Sinus & Allergy Centers [...]
Zealand Pharma – Completion of share buy-back program and related transactions (week 40 and 41, 2026)
05/10/2026
Company announcement No. 53 / 2026 Zealand Pharma - Completion of share buy-back program and related transactions (week 40 and 41, 2026) Copenhagen, Denmark, October 5, 2026 – Zealand Pharma A/S ("the Company" or “ [...]
Global Alzheimer's Platform Foundation Names New Medical Director at Tampa Research Site
05/10/2026
WASHINGTON, D. C. , Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform Foundation ® (GAP), announced today that Dr. Jeffery Greenberg is joining GAP as the Medical Director and Principal Investigator of [...]
Declaration of shares and voting rights - Status as of September 30, 2026
05/10/2026
VALNEVA Declaration of shares and voting rights Status as of September 30, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot [...]
Déclaration d’actions et de droits de vote - Statut au 30 septembre 2026
05/10/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 30 septembre 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège [...]
Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension
05/10/2026
Two oral presentations at AHA Hypertension 2026 will highlight the substantial antihypertensive efficacy of aprocitentan in two hypertension populations from the PRECISION study: patients with obesity and patients [...]
Sironax Named to Fierce Biotech’s “Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026
05/10/2026
Recognized for bold approach to addressing therapeutic targets WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for [...]
Ostia Sciences Publishes Second International Patent Application Covering the Sorbitol Switch That Drives Production of Phosphorylated Lantibiotics
05/10/2026
WO 2026/178627 covers methods, uses and compositions pairing Streptococcus salivarius SALI-10 with sorbitol, creating a synbiotic system designed to support the strain and increase production of its phosphorylated [...]
Medicovestor Announces FDA IND Clearance for MC001, Advancing to An International Phase 1 Study
05/10/2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Medicovestor, Inc. today announced FDA clearance of its Investigational New Drug (IND) application for MC001, the Company's first-in-class dimeric chemoimmunotherapy ADC for [...]
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
05/10/2026
– ABI-6250's pharmacodynamic analysis was recognized as a Poster of Distinction – SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company [...]
Research Peptide Companies: Kylo Peptides Scores 96.7/100 in Plastic Surgery Key Review
05/10/2026
Sheridan, Wyoming, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides https://kylopeptides.com/ [], a U.S.-based supplier of research-use-only peptides, has received a score of 96.7/100 in a Plastic Surgery Key review of [...]

Pages